A Clinical Study to Investigate Safety, Tolerability, Immunogenicity, and Preliminary Anti-Tumor Activity of KRAS Neoantigen mRNA Vaccine (ABO2102) in Participants With KRAS-mutated Advanced Pancreatic Cancer
Latest Information Update: 06 Sep 2024
At a glance
- Drugs Toripalimab (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Therapeutic Use
- 06 Sep 2024 New trial record